Retraction Note: Oroxylin A activates PKM1/HNF4 alpha to induce hepatoma differentiation and block cancer progression

Saved in:
Bibliographic Details
Main Authors: Libin Wei, Yuanyuan Dai, Yuxin Zhou, Zihao He, Jingyue Yao, Li Zhao, Qinglong Guo, Lin Yang
Format: Article
Language:English
Published: Nature Publishing Group 2025-03-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-025-07496-1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849772409766281216
author Libin Wei
Yuanyuan Dai
Yuxin Zhou
Zihao He
Jingyue Yao
Li Zhao
Qinglong Guo
Lin Yang
author_facet Libin Wei
Yuanyuan Dai
Yuxin Zhou
Zihao He
Jingyue Yao
Li Zhao
Qinglong Guo
Lin Yang
author_sort Libin Wei
collection DOAJ
format Article
id doaj-art-19cec7247f4e4d9ebefc6ce487e6ef25
institution DOAJ
issn 2041-4889
language English
publishDate 2025-03-01
publisher Nature Publishing Group
record_format Article
series Cell Death and Disease
spelling doaj-art-19cec7247f4e4d9ebefc6ce487e6ef252025-08-20T03:02:19ZengNature Publishing GroupCell Death and Disease2041-48892025-03-011611110.1038/s41419-025-07496-1Retraction Note: Oroxylin A activates PKM1/HNF4 alpha to induce hepatoma differentiation and block cancer progressionLibin Wei0Yuanyuan Dai1Yuxin Zhou2Zihao He3Jingyue Yao4Li Zhao5Qinglong Guo6Lin Yang7State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical UniversityState Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical UniversityState Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical UniversityState Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical UniversityState Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical UniversityState Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical UniversityState Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical UniversityState Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical Universityhttps://doi.org/10.1038/s41419-025-07496-1
spellingShingle Libin Wei
Yuanyuan Dai
Yuxin Zhou
Zihao He
Jingyue Yao
Li Zhao
Qinglong Guo
Lin Yang
Retraction Note: Oroxylin A activates PKM1/HNF4 alpha to induce hepatoma differentiation and block cancer progression
Cell Death and Disease
title Retraction Note: Oroxylin A activates PKM1/HNF4 alpha to induce hepatoma differentiation and block cancer progression
title_full Retraction Note: Oroxylin A activates PKM1/HNF4 alpha to induce hepatoma differentiation and block cancer progression
title_fullStr Retraction Note: Oroxylin A activates PKM1/HNF4 alpha to induce hepatoma differentiation and block cancer progression
title_full_unstemmed Retraction Note: Oroxylin A activates PKM1/HNF4 alpha to induce hepatoma differentiation and block cancer progression
title_short Retraction Note: Oroxylin A activates PKM1/HNF4 alpha to induce hepatoma differentiation and block cancer progression
title_sort retraction note oroxylin a activates pkm1 hnf4 alpha to induce hepatoma differentiation and block cancer progression
url https://doi.org/10.1038/s41419-025-07496-1
work_keys_str_mv AT libinwei retractionnoteoroxylinaactivatespkm1hnf4alphatoinducehepatomadifferentiationandblockcancerprogression
AT yuanyuandai retractionnoteoroxylinaactivatespkm1hnf4alphatoinducehepatomadifferentiationandblockcancerprogression
AT yuxinzhou retractionnoteoroxylinaactivatespkm1hnf4alphatoinducehepatomadifferentiationandblockcancerprogression
AT zihaohe retractionnoteoroxylinaactivatespkm1hnf4alphatoinducehepatomadifferentiationandblockcancerprogression
AT jingyueyao retractionnoteoroxylinaactivatespkm1hnf4alphatoinducehepatomadifferentiationandblockcancerprogression
AT lizhao retractionnoteoroxylinaactivatespkm1hnf4alphatoinducehepatomadifferentiationandblockcancerprogression
AT qinglongguo retractionnoteoroxylinaactivatespkm1hnf4alphatoinducehepatomadifferentiationandblockcancerprogression
AT linyang retractionnoteoroxylinaactivatespkm1hnf4alphatoinducehepatomadifferentiationandblockcancerprogression